Liposomal Doxorubicin and Interleukin-12 in Treating Patients With AIDS-Related Kaposi's Sarcoma

NCT00020449 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

NIH

Sponsor class

Conditions

Sarcoma

Interventions

BIOLOGICAL: recombinant interleukin-12
DRUG: paclitaxel
DRUG: pegylated liposomal doxorubicin hydrochloride

Sponsor

National Cancer Institute (NCI)